Form 4: Boston Scientific Executive Reports Share Disposals and Indirect Holdings
SEC Form 4 Filing
Joseph Michael Fitzgerald, an EVP at Boston Scientific, reported the disposal of 12,349 shares and indirect ownership of 4,894 shares held by his child.
Summary
- Joseph Michael Fitzgerald, an Executive Vice President at Boston Scientific, filed a Form 4 detailing changes in his beneficial ownership of company stock.
- On November 25, 2024, he disposed of 1,113 shares of common stock.
- On November 26, 2024, he disposed of an additional 11,236 shares of common stock.
- Both disposals were reported as gifts and had a price of $0.00 per share.
- Following these transactions, Mr. Fitzgerald directly owns 148,118 shares of Boston Scientific common stock.
- He also indirectly owns 4,894 shares through his child, for which he disclaims beneficial ownership.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing of stock transactions by an executive, which is neither positive nor negative in itself. It is a neutral event.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in the corporate world. It does not indicate any specific trend or event within the medical device industry.
Comparison to Industry Standards
- Executive stock transactions are a common occurrence in publicly traded companies, including those in the medical device sector like Medtronic (MDT) and Abbott (ABT).
- Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency and compliance with SEC regulations.
- The reported transactions are not unusual in terms of volume or nature when compared to similar filings by executives at comparable companies.
Stakeholder Impact
- The reported transactions are unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors as they are routine executive stock disposals.
Key Dates
| Date | Description |
|---|---|
| 11/25/2024 | Date of first reported share disposal of 1,113 shares. |
| 11/26/2024 | Date of second reported share disposal of 11,236 shares and date of filing. |
Keywords
Form 4, Beneficial Ownership, Boston Scientific, BSX, Executive Stock, Share Disposal, Joseph Michael Fitzgerald, Indirect Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.